This is a preview of subscription content, log in via an institution to check access.
Notes
Surveillance, Epidemiology, and End Results
References
Killelea BK, et al. Evolution of breast cancer screening in the medicare population: clinical and economic implications. Journal of the National Cancer Institute 106: No. 8, Aug 2014. Available from: URL: http://doi.org/10.1093/jnci/dju159.
Kerlikowske K, et al. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography. Journal of the National Cancer Institute 106: No. 8, Aug 2014. Available from: URL: http://doi.org/10.1093/jnci/dju191.
Rights and permissions
About this article
Cite this article
Rise in breast cancer screening costs not paying off in the US. PharmacoEcon Outcomes News 709, 8 (2014). https://doi.org/10.1007/s40274-014-1461-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1461-3